23.10.2017 • NewsElaine BurridgeCureVacEli Lilly

Lilly and CureVac in Cancer Vaccines Pact

(c) anyaivanova/Shutterstock
(c) anyaivanova/Shutterstock

In a deal that could lead to the development of five new cancer vaccines, US drugs giant Eli Lilly is investing in German biopharma CureVac.

Lilly will make an equity investment of $45 million in CureVac as well as an upfront payment of $50 million. However, the Tübingen-headquartered group could potentially receive more than $1.7 billion in development and commercialization milestones if all five vaccines are successfully developed, plus tiered royalties on product sales.

"We are excited to be collaborating with CureVac to discover what could potentially be the next frontier of cancer medicines," said Greg Plowman, vice president of oncology research at Lilly.

The collaboration will use CureVac's proprietary messenger RNA (mRNA) technology, RNActive, which targets tumour neoantigens for a more robust anti-cancer immune response. Lilly will be responsible for target identification, clinical development and commercialization. CureVac will be in charge of formulation and manufacturing clinical supplies and also has an option to co-promote the vaccines in Germany.

To date, CureVac has raised around $420 million in equity investments. Backers include the Bill & Melinda Gates Foundation and German private equity group dievini Hopp BioTech Holding.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.